Küleon’s first patent application published by WIPO and receives favorable PCT search report and written opinion from the World Intellectual Property Office for the disclosure of thousands of novel compounds based on 10+ unique molecular scaffolds. These include previously undescribed benzofuran, benzothiophene, benzoselenophene, and aza-indole analogs that exhibit unique serotonin receptor docking profiles and biological activities.
Please click the link below to read more:
